Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Jul 25, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment approach for Oral Lichen Planus (OLP), a long-lasting condition that affects the inside of the mouth and can cause discomfort and pain. The researchers are looking at how a traditional Chinese medicine called paeoniflorin, when combined with a special light therapy called photodynamic therapy, can help manage this condition better than current treatments. They hope this study will provide new insights into treating OLP and potentially improve the quality of life for patients.

To participate in this trial, individuals must be at least 18 years old and diagnosed with Oral Lichen Planus. Those who are pregnant, have serious health issues like heart or kidney problems, or have any tumors are not eligible. Participants will be randomly assigned to receive either the new treatment or standard care, and they will be closely monitored throughout the study. By joining this trial, participants may not only receive potential benefits for their condition but also contribute to important research that could help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with oral lichen planus
• • male or female patients older than 18 years of age
• • patients willing to participate with signed informed consent.
• Exclusion Criteria:
• • pregnant or lactating
• • had serious systemic diseases of the heart, lung, liver, and kidney, or had tumors
• • were unwilling to participate in the experiment.